Vinblastine
Showing 26 - 50 of 281
Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor Trial in Villejuif (carboplatin, cisplatin, cyclophosphamide)
Completed
- Extragonadal Germ Cell Tumor
- Testicular Germ Cell Tumor
- carboplatin
- +8 more
-
Villejuif, FranceInstitut Gustave Roussy
Feb 19, 2021
Stage IV Melanoma Trial in Cleveland (recombinant interferon alfa-2b, cisplatin, sodium stibogluconate)
Completed
- Stage IV Melanoma
- recombinant interferon alfa-2b
- +4 more
-
Cleveland, OhioCleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Jul 22, 2020
Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)
Active, not recruiting
- Advanced Hodgkin Lymphoma
- Brentuximab Vedotin
- +6 more
-
Antwerp, Belgium
- +18 more
May 4, 2022
Lymphoma Trial in Southampton (bleomycin sulfate, filgrastim, pegfilgrastim)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +10 more
-
Southampton, England, United KingdomSouthampton General Hospital
Apr 27, 2021
Lymphoma Trial (biological, drug, radiation)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +7 more
- (no location specified)
Feb 2, 2021
Advanced Classical Hodgkin's Lymphoma in Brazil Treated With
Not yet recruiting
- Hodgkin Lymphoma
- No Intervention
-
Salvador, Bahia, Brazil
- +5 more
Oct 23, 2023
Melanoma Trial in Houston (Temozolomide, Velban, Cisplatin)
Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United
Active, not recruiting
- Ann Arbor Stage IB Hodgkin Lymphoma
- +10 more
- Brentuximab Vedotin
- Nivolumab
-
Palo Alto, California
- +8 more
Jul 20, 2022
Hodgkin Lymphoma, Adult Trial in Moscow (Doxorubicin, Bleomycin, Vinblastine)
Recruiting
- Hodgkin Lymphoma, Adult
- Doxorubicin
- +7 more
-
Moscow, Russian FederationThe Federal Budget-Funded Institution National Medical Surgical
Nov 20, 2020
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Lymphoma Trial in Stanford (Bleomycin sulfate, Stanford V regimen, Doxorubicin HCl)
Completed
- Lymphoma
- Bleomycin sulfate
- +7 more
-
Stanford, CaliforniaStanford Cancer Center at Stanford University Medical Center
Aug 10, 2020
AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United
Active, not recruiting
- AIDS-Related Hodgkin Lymphoma
- +11 more
- Brentuximab Vedotin
- +4 more
-
La Jolla, California
- +27 more
Jul 27, 2022
Bladder Cancer Trial in Rouen (GEMCITABINE CISPLATINE, METHOTRXATE VINBLASTINE DOXORUBICINE CISPLATINE G-CSF)
Active, not recruiting
- Bladder Cancer
- GEMCITABINE CISPLATINE
- METHOTRXATE VINBLASTINE DOXORUBICINE CISPLATINE G-CSF
-
Rouen, FranceUHRouen
Jan 10, 2020
High Grade Upper Tract Urothelial Carcinoma Trial in United States (Methotrexate, Vinblastine, Doxorubicin)
Completed
- High Grade Upper Tract Urothelial Carcinoma
- Methotrexate
- +7 more
-
Birmingham, Alabama
- +133 more
Aug 9, 2022
Vinca Alkaloid Adverse Reaction Trial (Loratadine, Diosmin/ Hesperidin)
Not yet recruiting
- Vinca Alkaloid Adverse Reaction
- Loratadine
- Diosmin/ Hesperidin
- (no location specified)
Feb 14, 2022
Solid Tumors, CNS Tumors Trial in Canada, United States (Vinblastine and Sirolimus)
Completed
- Solid Tumors
- Central Nervous System Tumors
- Vinblastine and Sirolimus
-
San Diego, California
- +4 more
Sep 17, 2019
Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,
Unknown status
- Classical Hodgkin Lymphoma
- +3 more
- Adriamycin
- +5 more
-
Riyadh, Saudi ArabiaKing Abdulaziz Medical City, Ministry of National Guard
Nov 14, 2019
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
-
Fountain Valley, California
- +75 more
Dec 2, 2022
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse
Unknown status
- Carcinoma, Non-Small-Cell Lung
- Immune-Related Adverse Events
- PD-1 inhibitor
- Chemotherapy Drugs, Cancer
- (no location specified)
May 27, 2020
Renal Pelvis and Ureter Urothelial Carcinoma Trial in United States (drug, biological, procedure)
Recruiting
- Renal Pelvis and Ureter Urothelial Carcinoma
- Biopsy
- +11 more
-
Fort Smith, Arkansas
- +206 more
Jan 26, 2023